Category: Baxter International
Ali Haghighi-Mood, the former president & CEO of Cambridge Heart, and chairman Roderick de Greef both resign for unnamed reasons.
Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.
A Federal Circuit court refuses to re-hear the case after a lower court throws out Baxter's $23.5 million win against Fresenius, which was charged with infringement of hemodialysis patents.
Baxter International warns patients on a potential software issue with its HomeChoice automated dialysis device.
Baxter (NYSE:BAX) warned patients with ascites of a potential software problem with its HomeChoice peritoneal dialysis machine that could cause low blood pressure and "hemodynamic compromise," according to a field alert.
Baxter International's 3rd-quarter earnings meet Wall Street's expectations but the delayed closing of its $4 billion acquisition of Gambro results in a top-line miss.
Baxter (NYSE:BAX) managed to meet Wall Street analysts' expectations with its 3rd-quarter earnings, but revenues for the healthcare conglomerate fell $40 million shy, sending shares down slightly this morning.
Australia's CSL Ltd. agrees to pay $64 million to settle a price-fixing lawsuit over plasma therapy.Australia's CSL Ltd. agrees to pay $64 million to settle a price-fixing lawsuit over plasma therapy.
CSL Ltd. (ASX:CSL) said it agreed to pay $64 million to settle multi-district litigation accusing it of taking part in a price-fixing scheme for plasma therapy.
Medical device maker Baxter lays off nearly 100 employees from its Medina, N.Y., facility that manufactures the Sigma Spectrum infusion pump at the center of an FDA inquiry.
Healthcare giant Baxter (NYSE:BAX) announced that it fired nearly 100 employees from a Medina, N.Y., amid an FDA inquiry into the Sigma Spectrum infusion pump manufactured there.
"Particular matter" found in the packaging of some of Baxter's Dual Luer lock caps may cause thrombotic and embolic events, spurring a company recall and an FDA Class I label, designating the highest-risk medical device issue.
Healthcare giant Baxter (NYSE:BAX) recalled 2 lots of its Dual Luer Lock Caps after finding "particular matter" loose in the devices' packaging, the company announced last week. The measure got the FDA's highest-risk Class I label.